tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Forte Biosciences price target lowered to $61 from $64 at Chardan

Chardan lowered the firm’s price target on Forte Biosciences (FBRX) to $61 from $64 and keeps a Buy rating on the shares. The firm updates its model after the company’s FY24 update and expectations of Celiac Disease data expected in Q2.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1